Buccal misoprostol for treatment of fetal death at 14-28 weeks of pregnancy: a double-blind randomized controlled trial
- March 13th, 2014
- Staff Publication
- Pregnancy Failure and Miscarriage
- Bracken, Hillary, Winikoff, Beverly, Blumenthal, Paul, D., Buccal misoprostol for IUFD Research Group, Ngoc, N.T., Banks, E., Derman, R.J., Patel, A., Gold, M.
This study sought to assess whether buccal misoprostol is effective for treating intrauterine fetal death. The authors found that a 200 mcg dose, repeated at 6-hour intervals, was more effective than a 100 mcg dose in evacuating the uterus within 48 hours.
Access the abstract.